Health Policy in China

Health Policy in China


The Duke-Margolis team has engaged with key health system leaders from China to advance journey towards care delivery and payment reform. 

See specific projects below


Health delivery and payment transformation in China

The Center is involved in several initiative to support care transformation and improvements in China’s health care delivery and payment systems. The Center is helping lead an ongoing bilateral discussion hosted by the National Committee on US-China Relations to identify potential paths for accelerating care transformation in both countries. The Center has also explored projects in care and health delivery reforms with a range of partners, including the World Bank, the National Health Security Administration (NHSA), and the Chinese Academy of Social Sciences. 

med products

Medical product regulatory reform in China

The Center has engaged with the National Medical Product Administration to help bring clinical trials and evidentiary standards in-line with international best practices. 

Duke-Margolis Team

Mark McClellan

Mark McClellan, MD, PhD

Director of Margolis Center
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty


Aparna Higgins

Senior Policy Fellow

Susan Dentzer

Susan Dentzer

Senior Policy Fellow